Tae Han

Woodinville, Washington, United States
Dr. Han joined ProfoundBio with extensive experience in drug development focused on preclinical development, translational medicine, and clinical pharmacology. In his career, Dr. Han supported multiple compound modalities, including small molecules, antibody-drug conjugates (ADCs), and bispecific antibody products, from discovery through commercialization. Dr. Han has extensive experience with ADCs and supported the development of two approved products, ADCETRIS(TM) and PADCEV(TM). Dr. Han received his B.S. in Chemical Engineering from the University of Washington, and Ph.D. in Chemical and Biomolecular Engineering from the University of California, Los Angeles where he also trained as a post-doctoral fellow in the School of Medicine, Division of Cardiology.
Speaking In
3:30 PM - 5:00 PM (PDT)
Monday, June 13
Learn the latest about biomedical innovation within the China biotech community from this showcase…